علم الدم
النتائج السريرية
Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial. (يفتح نافذة جديدة)
Source: Lancet Haematol 2018;5(3):e117-e126.
مفهرسة: PubMed 29396092
DOI: 10.1016/S2352-3026(18)30016-4
https://www.ncbi.nlm.nih.gov/pubmed/29396092 (يفتح نافذة جديدة)
Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (يفتح نافذة جديدة)
Source: Cancer 2013;119(1):107-14.
مفهرسة: PubMed 22744794
DOI: 10.1002/cncr.27686
https://www.ncbi.nlm.nih.gov/pubmed/22744794 (يفتح نافذة جديدة)